Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease in End-points through Aggressive Lipid-lowering Trial (IDEAL)

Author： Holme Ingar   Cater Nilo   Faergeman Ole   Kastelein John   Olsson Anders   Tikkanen Matti   Lytken Larsen Mogens   Lindahl Christina   Pedersen Terje  

Publisher： Informa Healthcare

ISSN： 0785-3890

Source： Annals of Medicine, Vol.40, Iss.6, 2008-01, pp. : 456-464

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lipoprotein lipase Hin dIII polymorphism influences HDL-cholesterol levels in statin-treated patients with coronary artery disease

By Javorský Martin   Gašperíková Daniela   Ukropec Jozef   Sedláková Barbora   Riečanský Igor   Križanová Ol'ga   Šeböková Elena   Dobríková Martina   Klimeš Iwar   Tkáč Ivan  

Wiener klinische Wochenschrift, Vol. 119, Iss. 15-16, 2007-08 ,pp. : 476-482

Springer Publishing Company

Access to resources Recommend Favorite

Underutilization of Measurement of Serum Low‐Density Lipoprotein Cholesterol Levels and of Lipid‐Lowering Therapy in Older Patients with Manifest Atherosclerotic Disease

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 46, Iss. 9, 1998-09 ,pp. : 1128-1131

John Wiley & Sons Inc

Access to resources Recommend Favorite

Do Lipid Lowering Drugs Reduce the Risk of Coronary Heart Disease?

By Pritzker L. B.  

Critical Reviews in Clinical Laboratory Sciences, Vol. 35, Iss. 6, 1998-12 ,pp. : 603-621

Informa Healthcare

Access to resources Recommend Favorite

Atherogenic dyslipidemia as evidenced by the lipid triad: prevalence and associated risk in statin-treated patients in ambulatory care

By Bestehorn Kurt   Smolka Wenefrieda   Pittrow David   Schulte Helmut   Assmann Gerd  

Current Medical Research and Opinion, Vol. 26, Iss. 12, 2010-12 ,pp. : 2833-2839

Informa Healthcare

Access to resources Recommend Favorite

ApoB/A1 and LDL-C/HDL-C and the prediction of cardiovascular risk in statin-treated patients

By Liem A. H.   van de Woestijne A. P.   Roeters van Lennep H. W. O.   Zwinderman A. H.   van der Steeg W. A.   Jukema J. W.  

Current Medical Research and Opinion, Vol. 24, Iss. 2, 2008-02 ,pp. : 359-364

Informa Healthcare

Access to resources Recommend Favorite